Up-regulated N-cadherin expression is associated with poor prognosis in epithelial-derived solid tumors: a meta-analysis. (scientific article published on 5 February 2018)

Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition

Q24316645

Anomalous cadherin expression in osteosarcoma. Possible relationships to metastasis and morphogenesis

Q24670457

Clinical implications of N-cadherin expression in gastric cancer

Q83502689

Nuclear expression of N-cadherin correlates with poor prognosis of nasopharyngeal carcinoma

Q83560796

Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer

Q85893330

Loss of N-cadherin is associated with loss of E-cadherin expression and poor outcomes of liver resection in hepatocellular carcinoma

Q86089769

A combined modality of carboplatin and photodynamic therapy suppresses epithelial-mesenchymal transition and matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in HEp-2 human laryngeal cancer cells via ROS-mediated inhibition of MEK/ERK signalling

Q88040443

Expression of E- and N-cadherin and clinicopathology in hepatocellular carcinoma

Q95820059

Practical methods for incorporating summary time-to-event data into meta-analysis

Q28131754

Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance

Q30500080

Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study

Q33840690

Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas

Q33919265

A catalogue of reporting guidelines for health research

Q34091472

microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R.

Q34120352

Prognostic significance of twist and N-cadherin expression in NSCLC.

Q34692838

Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk

Q34978755

Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation

Q34978807

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers

Q35169094

Down-regulated E-cadherin expression is associated with poor five-year overall survival in bone and soft tissue sarcoma: results of a meta-analysis

Q35231155

Expression of E-cadherin, N-cadherin and snail and their correlation with clinicopathological variants: an immunohistochemical study of 132 invasive ductal breast carcinomas in Egypt.

Q35232419

E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma

Q35653917

Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomas.

Q35764354

N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling

Q35878904

Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion

Q36257715

ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition

Q36261743

N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression

Q36294742

Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis

Q36316373

Expression of molecular factors correlated with metastasis in small cell lung cancer and their significance

Q36464564

New signals from the invasive front

Q36488744

Cadherin switching

Q37102948

Cadherins in development and cancer

Q37218718

Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer

Q37427965

Cadherins as novel targets for anti-cancer therapy

Q37616415

Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients

Q38309443

Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma

Q38433795

Meta-analysis of downregulated E-cadherin as a poor prognostic biomarker for cervical cancer

Q38665146

Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma

Q38735435

Oncogenic role of epithelial cell transforming sequence 2 in lung adenocarcinoma cells.

Q38742633

PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway

Q38752801

Synergistic inhibition of characteristics of liver cancer stem-like cells with a combination of sorafenib and 8-bromo-7-methoxychrysin in SMMC-7721 cell line

Q38755520

Mechanism of c-Met and EGFR tyrosine kinase inhibitor resistance through epithelial mesenchymal transition in non-small cell lung cancer.

Q38758979

Involvement of the MEK/ERK pathway in EGF-induced E-cadherin down-regulation

Q38760412

The prognostic role of E-cadherin and β-catenin overexpression in laryngeal squamous cell carcinoma

Q38948841

Expression and significance of E-cadherin, N-cadherin, transforming growth factor-β1 and Twist in prostate cancer

Q39034911

Epithelial-Mesenchymal Expression Phenotype of Primary Melanoma and Matched Metastases and Relationship with Overall Survival

Q39128697

Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1.

Q39411956

Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma

Q39503251

Epithelial-Mesenchymal Transition in Chronic Rhinosinusitis: Differences Revealed Between Epithelial Cells from Nasal Polyps and Inferior Turbinates

Q39619617

N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition

Q39620571

Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors

Q40158466

Expression of α5-integrin, α7-integrin, Ε-cadherin, and N-cadherin in localized prostate cancer

Q40227431

High expression of lncRNA PVT1 promotes invasion by inducing epithelial-to-mesenchymal transition in esophageal cancer

Q41195899

Reduced E-Cadherin expression is a prognostic biomarker of non-small cell lung cancer: a meta-analysis based on 2395 subjects

Q41637140

Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells.

Q41679466

Long form collapsin response mediator protein-1 promotes the migration and invasion of osteosarcoma cells

Q42026087

Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.

Q42445173

A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer

Q42522113

The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status.

Q43614338

Signal transduction from N-cadherin increases Bcl-2. Regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization

Q44049207

α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma

Q44711229

Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment

Q46593339

Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer

Q46625804

Overexpression of AIB1 correlates inversely with E-cadherin expression in pancreatic adenocarcinoma and may promote lymph node metastasis

Q46662072

N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma

Q47290074

Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas

Q48543014

The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain.

Q48769583

CCL22 and IL-37 inhibit the proliferation and epithelial-mesenchymal transition process of NSCLC A549 cells

Q49131789

Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells.

Q51495480

N-Cadherin Aided in Maintaining the Characteristics of Leukemic Stem Cells.

Q52875775

Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma.

Q53627868

Clinicopathologic correlations of liver kinase B1, E-cadherin, and N-cadherin expression in non-small cell lung cancer.

Q54465941

Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors

Q80356575

ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression

Q80848915

N-cadherin switching occurs in high Gleason grade prostate cancer

Q81237591

Neural cadherin overexpression is a predictive marker for early postoperative recurrence in hepatocellular carcinoma patients

Q81458955

P275

Creative Commons Attribution-NonCommercial

Q6936496

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

glandular and epithelial neoplasm

cadherin

tumor biomarker

on focus list of Wikimedia project

ScienceSource

Q55439927

P577

publication date

2018-02-25

2018-04-01

P1433

published in

European Journal of Clinical Investigation

Q15745208

P1476

title

Upregulated N-cadherin expression is associated with poor prognosis in epithelial-derived solid tumours: A meta-analysis

P478

volume

Reverse relations

cites work (P2860)

Q100307389	Annurca apple polyphenol extract promotes mesenchymal-to-epithelial transition and inhibits migration in triple-negative breast cancer cells through ROS/JNK signaling
Q60909654	Biological Aggressiveness of Subclinical No-Mass Ductal Carcinoma In Situ (DCIS) Can Be Reflected by the Expression Profiles of Epithelial-Mesenchymal Transition Triggers
Q58716411	Chalcone Derivatives 4'-Amino-1-Naphthyl-Chalcone (D14) and 4'-Amino-4-Methyl-1-Naphthyl-Chalcone (D15) Suppress Migration and Invasion of Osteosarcoma Cells Mediated by p53 Regulating EMT-Related Genes
Q93257727	Filopodia play an important role in the trans-mesothelial migration of ovarian cancer cells
Q90398667	Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties
Q92701866	N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study
Q57052686	N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer
Q64076469	Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming
Q92714278	Targeting ROR1 inhibits epithelial to mesenchymal transition in human lung adenocarcinoma via mTOR signaling pathway
Q90433803	The Leader Position of Mesenchymal Cells Expressing N-Cadherin in the Collective Migration of Epithelial Cancer
Q97537455	Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancer
Q89894933	[Research Advances in the Mechanism of Invasion and Metastasis of Circulating Tumor Cells in Lung Cancer]